4^th International Conferences in Lung Disease & Respiratory Health June 12-13, 2023 Prague, Czech Republic

4^th  International Conferences on Lung Diseases  Going to held on  June 12-13, 2023 in as a webinar Pulmonology focuses specially focuses on diagnosing and treating disorders of the respiratory system. Lung Diseases 2023 empower entries from analysts based generally in, Europe, USA and Asian nations. The promising challenge of the field is to evaluate current problems and resolve them accordingly. The main aim is to have a lung health awareness of global public, and also provide a platform for pulmonologists to share and discuss their views which plays a key role in the development of enhanced diagnostic and treatment methods for further improving the quality of life in people suffering from lung disorders.

TRACK 1:  Occurrence of Pneumonia in Lungs

Pneumonia means inflammation of one or both lungs that is usually caused by an infection. Other germs like bacteria, viruses and fungi can also cause pneumonia. When you breathe in these germs in the air they can settle in the alveoli of your lungs. Deep in your lungs, the germs may settle in lung lobes and damage it eventually. After once the lungs got infected the alveoli in the lungs starts filling up with puss and mucus. This swelling of the air sacs makes them less extendible and keeps oxygen from properly reaching your blood thirstiest.

TRACK 2:  Idiopathic Pulmonary Fibrosis

Excess exposure to the Hazardous chemicals and coal dust results to pulmonary fibrosis. Scarring of the lungs for an unknown reason is known as Idiopathic Pulmonary Fibrosis. Repetitive lung injury happens to the Idiopathic Pulmonary Fibrosis in the lung alveoli.

• Dry cough that doesn’t go away
• Chest pain or tightness
• Leg swelling
• Loss of appetite
• Shortness of breath at Physical activities.

TRACK 3:  Cardio Pulmonary Disorders

Cardiopulmonarydisorders is the range between the heart and the lungs. Pulmonary Hyper tension results to Decrease in the percentage of Oxygen in the lungs. Oxygenation failure in the lungs leads to

• Alveolar Edema
• Emphysema
• Leukemia
• Lung carcinoma
• Lobar Pneumonia
• Tuberculosis

 TRACK 4:  Betterment of Lung Abscess

A Lung Abscess is usually caused by bacteria that normally live in the mouth or throat and that are inhaled into the lungs causes infection. Obstruction of the airways in the thoracic cavity also can lead to abscess formation. Lung abscesses is formed when bacteria or infected blood clots travel through theblood fluids to the lung from another infected site in the body.

For Betterment Antibiotic Therapy:

Antibiotics intake is required. Antibiotics are initially given through a vein and later through mouth if the person’s condition is normal. Antibiotic treatment continues until the symptoms disappear and a chest x-ray shows that the abscess has cleared up. Such improvement usually requires 3 to 6 weeks of antibiotic therapy even it might take longer period of time as well

TRACK 5:  Prevention and Control of Respiratory Diseases

Environmental management is a crucial part of therapy in abnormal respiratory diseases. Ventilation in the cooking area and workspace leads to the major decrease of microbes and bacteria. A removal of Dampness around the living area creates freshness and recreates the environmental healthiness. Improving the Respiratory health helps for the improvement of proper Blood circulation and Airflow into the alveoli of the lungs.

Some of the ways that helps to Control Chronic Respiratory diseases

• Avoiding smoking and second hand smoke
• Improving good BMI
• Avoidance of Air pollution.
• Taking care from germs and Allergens.
• Avoiding Exposure to Flu effected persons.
• Maintenance of proper Ventilation in living area

TRACK 6: Lung Transplantation

The process of transfer of infected lung from a healthy donor is referred as lung transplantation. Person effecting with lung infections are not advisable to be a donor. The donor tissue should be matched as to your tissue.

• Risk involved in Lung transplantation
• Types of Lung transplantation
• Age criteria for Lung transplantation

TRACK 7:  Impact of COVID-19 on Lungs

COVID-19, shows much impact on lungs as it slaughter the lungs by causing minor illness like cough , cold  and another possible complication of COVID-19, can also cause abiding  harm to the lungs and other organs. It causes respiratory tract infections that can range from mild to lethal in human like other respiratory illnesses, COVID-19, the disease caused by the new coronavirus, can cause enduring lung damage it affects the lungs while people are sick with lung disorders and even  after recovery.

TRACK 8:  Abnormalities in breathing regulation

Abnormalities in breathing regulation include apnea, eupnea, orthopnea, dyspnea, hyperpnea, Hyper and Hypo ventilation, hypoventilation, tachypnea, kussmaul respiration, Cheyne - Stokes respiration, sighing respiration, biot respiration, apneustic breathing, central neurogenic hyperventilation, and central neurogenic hypoventilation. Abnormality in breathing leads to Inflammation of lungs and occurrence of Apnea which in abnormal respiration in sleep. It leads to Destruction of Mental health and illness in human.

TRACK 9:  Interstitial Lung Disease

Interstitial Lung Disease is also known as pulmonary fibrosis. Scarring of lung tissue happens in the process of pulmonary fibrosis. Hence results to stiffness of Lung tissue. It is an Increasing disease, and at present there is no cure for damage caused by scarring and swelling of the lung tissue. Lung tissue analysis is performed to diagnose the disease.

• Bronchoscopy
• Bronchoalveolar lavage.
• Surgical biopsy
• Pulmonary rehabilitation
• Oxygen therapy

TRACK 10: Occupational & Environmental lung Disease

Occupational and environmental lung diseases are caused by the inhalation of toxic and hazardous chemicals in and around the work station and living area. Diseases are caused by exposure to germs and harmful chemicals. Intake of harmful gases, continuous exposure at coal mines leads to the breathing difficulty which results into the damage of lung tissue.

TRACK 11: Knowledge on Chronic bronchitis and Pulmonary Hypertension

Pulmonary hypertension is a type of high blood pressure arises at the right side of your heart closest to the lung lobe. It occurs due to congenital heart disease, High blood pressure, liver disease. High blood pressure in the arteries to your lungs is dangerous condition. Your heart has to pump high volume of blood through. Medication and oxygen therapy gives the best results in improving the quality of life.

MESH TERMS:

• Heart Failure / epidemiology
• Pulmonary Embolism / epidemiology
• Vascular Resistance / physiology
• Hypertension, Pulmonary / etiology

TRACK 12: Effect of Thoracic tumors on Lungs

The spread of cancer cells onto the lung lobes results in the blockage of Air sacs around the lungs. When people breathe in dangerous, toxic substances the change in lung cell happens and it gets replicated as hence causes tumors. Lung cancer happens at lymph nodes within the lung. At early stages you cannot feel or see the tumors        in the lung, Later often you get Cough, sneezing and wheezing but there is some other which can be shown out too.

TRACK 13: COPD Exacerbations

A person with chronic obstructive pulmonary disease (COPD) experiences long-term, progressive damage to their lungs which affects the airflow to the lungs this condition is referred as emphysema or chronic bronchitis. If the symptoms are severe than earlier at COPD then this condition is termed as acute exacerbation. COPD exacerbation symptoms are Cough |Decrease in the Oxygen level |Wheezing more than normal | Low immunity. Home treatment to overcome COPD Exacerbations are

• Antibiotics
• Inhalers
• Steroids

The global respiratory disease testing/diagnostics market size was valued at USD 5.0 billion in 2016 and is expected to grow at a CAGR of 3.3% over the forecast period. Constantly rising incidence of respiratory diseases owing to escalating air pollution levels is the prime factor driving the growth of the market. As reported by CDC, Chronic Obstructive Pulmonary Disease (COPD) was the third main cause of death in the U.S. in 2014.

The rising rate of pollutants in the air and the release of hazardous gases causing lung diseases including COPD and other respiratory diseases around the world is driving the market. The other factors driving the overall growth include spread of infections such as tuberculosis and hospital-acquired infection where these tests are used as a preliminary detection tool.

Industry Insights

The global respiratory disease testing/diagnostics market size was valued at USD 5.0 billion in 2016 and is expected to grow at a CAGR of 3.3% over the forecast period. Constantly rising incidence of respiratory diseases owing to escalating air pollution levels is the prime factor driving the growth of the market. As reported by CDC, Chronic Obstructive Pulmonary Disease (COPD) was the third main cause of death in the U.S. in 2014.

The rising rate of pollutants in the air and the release of hazardous gases causing lung diseases including COPD and other respiratory diseases around the world is driving the market. The other factors driving the overall growth include spread of infections such as tuberculosis and hospital-acquired infection where these tests are used as a preliminary detection tool.

Global respiratory disease testing market, by product, 2014 - 2025 (USD Million)

The adoption of imaging technologies, such as Computed Tomography (CT), in COPD diagnosis, is expected to drive the growth. Use of technically advanced devices, such as pulse oximeters, for effective management of COPD in outpatients is rapidly gaining recognition in the market place. Also, shift to noninvasive mechanical ventilation for COPD is expected to fuel the market growth.

Product Insights

Imaging tests captured the largest revenue share of the global respiratory disease testing market in 2016. The prime reason for the dominance of the segment is increased adoption of x-ray imaging and other imaging modalities for better visualization and a clear picture of disease condition. Furthermore, increasing demand for CT imaging is expected to drive the growth. As a result, the segment is expected to maintain its dominance throughout the forecast period.

Respiratory measurement devices, also referred to as respirometers, include spirometers, pulse oximeters, capnography, and peak flowmeters. Rising demand for pulse oximeters in this segment is higher compared to other devices. Accurate and effective diagnosis in a short time and preference for these tests by physicians are expected to trigger the growth of the segment over the forecast period.